Cargando…

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension

Dasatinib is a small-molecule tyrosine kinase inhibitor used in the treatment of hematological malignancies. Pulmonary arterial hypertension (PAH) is a rare but known complication. The mainstay of treatment is cessation of Dasatinib, and while clinical improvement is rapid, complete hemodynamic reso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jose, Arun, Rafei, Hind, Ahari, Jalil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703121/ https://www.ncbi.nlm.nih.gov/pubmed/28644066 http://dx.doi.org/10.1177/2045893217716659

Ejemplares similares

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy
por: Nishimori, Makoto, et al.
Publicado: (2018)

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
por: Hong, Ji Hyung, et al.
Publicado: (2015)

Dasatinib-induced Pulmonary Hypertension
por: Tamura, Yudai, et al.
Publicado: (2022)

Predictive value of pulmonary function testing in the evaluation of pulmonary hypertension in sarcoidosis
por: Jose, Arun, et al.
Publicado: (2018)

Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
por: Skride, Andris, et al.
Publicado: (2017)

Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report
por: Toya, Takumi, et al.
Publicado: (2019)

Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors
por: El-Dabh, Ashraf, et al.
Publicado: (2019)

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib
por: Seegobin, Karan, et al.
Publicado: (2017)

Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose
por: Kubota, Kana, et al.
Publicado: (2022)

Combination therapy with pulmonary arterial hypertension targeted drugs and immunosuppression can be a useful strategy for sarcoidosis-associated pulmonary hypertension: a case report
por: Sumimoto, Keiko, et al.
Publicado: (2020)

Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy
por: Jin, Wenying, et al.
Publicado: (2022)

Pulmonary Arterial Hypertension Specific Therapy in Patients with Combined Post- and Precapillary Pulmonary Hypertension
por: Alfraidi, Hassan, et al.
Publicado: (2018)

Pulmonary Arterial Hypertension: Combination Therapy in Practice
por: Burks, Marsha, et al.
Publicado: (2018)

Pulmonary hypertension and pulmonary artery dissection
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2013)

The impact of pulmonary arterial hypertension-targeted therapy on survival in Chinese patients with idiopathic pulmonary arterial hypertension
por: Zeng, Wei-Jie, et al.
Publicado: (2012)

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
por: Hennigs, Jan K, et al.
Publicado: (2011)

Is pulmonary arterial hypertension associated with schistosomiasis distinct from pulmonary arterial hypertension associated with portal hypertension?
por: Graham, Brian B., et al.
Publicado: (2023)

Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling
por: Wang, Rui, et al.
Publicado: (2022)

Impact of targeted pulmonary arterial hypertension therapies in severe pulmonary hypertension in chronic lung diseases
por: Naud, Romain, et al.
Publicado: (2023)

Resolution of Periodic Breathing in a Child with Idiopathic Pulmonary Arterial Hypertension
por: Bin-Hasan, Saadoun, et al.
Publicado: (2017)

The evolving landscape of combination therapy for pulmonary arterial hypertension
por: Griffin, Matthew, et al.
Publicado: (2016)

The role of combination therapy in managing pulmonary arterial hypertension
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2014)

Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report
por: L, Chomette, et al.
Publicado: (2021)

Pulmonary arterial hypertension and pregnancy
por: Terek, Demet, et al.
Publicado: (2013)

Rho-Kinase Inhibition Ameliorates Dasatinib-Induced Endothelial Dysfunction and Pulmonary Hypertension
por: Fazakas, Csilla, et al.
Publicado: (2018)

Improvement of pulmonary arterial compliance by pulmonary vasodilator in pulmonary hypertension from combined pulmonary fibrosis and emphysema
por: Kusaka, Kei, et al.
Publicado: (2019)

Pulmonary arterial hypertension associated with pulmonary arteriovenous malformations and pulmonary veno-occlusive disease: A devastating combination
por: Zaaijer, Baukje M., et al.
Publicado: (2021)

Upfront triple combination therapy-induced pulmonary edema in a case of pulmonary arterial hypertension associated with Sjogren's syndrome
por: Takeuchi, Kimikazu, et al.
Publicado: (2017)

Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase
por: Takatsuka, Ibuki, et al.
Publicado: (2022)

Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension
por: Gerthoffer, William
Publicado: (2020)

Combination Therapy in Pulmonary Arterial Hypertension—Targeting the Nitric Oxide and Prostacyclin Pathways
por: Mandras, Stacy, et al.
Publicado: (2021)

Incident pulmonary arterial hypertension associated with Bosutinib
por: Yo, Shaun, et al.
Publicado: (2020)

Epoprostenol‐associated ascites in pulmonary arterial hypertension
por: Schoenberg, Noah C., et al.
Publicado: (2022)

Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Publicado: (2021)

Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry
Publicado: (2022)

Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension
por: Hoette, Susana, et al.
Publicado: (2015)

Massive dilatation of the pulmonary artery in association with pulmonic stenosis and pulmonary hypertension
por: Morjaria, Sejal, et al.
Publicado: (2012)

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension
por: Badagliacca, Roberto, et al.
Publicado: (2022)

The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis
por: Lee, Michael H, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m82fp61hnfaqt7r77esl2dm2es